- 27 yo woman
- 10 year history
- erratic scanty painful menstruation
- thinning hair
- facial hair increasingly prominent
- intermittently on contraceptive pills
- without them, menstrual cycle only every 6 months
- increased fasting insulin
- increased total testosterone
- increased cholesterol
- increased TG
- increased LDL, decreased HDL
- TG/HDL ratio increased (insulin resistance)
- Ultrasound of pelvis
- normal sized uterus
- thickened stroma of ovaries
- peripheral distribution of small cysts
- Congenital adrenal hyperplasia
- Endocrine problem
- Non functioning ovary
Extra learning issues:
Polycystic ovarian syndrome
The principal features are
- anovulation (resulting in irregular menstruation) or amenorrhea
- excessive amounts or effects of androgenic (masculinizing)
- insulin resistance
- insulin resistance (leading cause)
- from glucose tolerance test
Polycystic ovaries develop when the ovaries are stimulated to produce excessive amounts of male hormones (androgens), particularly testosterone, either through the release of excessive luteinizing hormone (LH) by the anterior pituitary gland or through high levels of insulin in the blood (hyperinsulinaemia) in women whose ovaries are sensitive to this stimulus.
The syndrome acquired its most widely used name due to the common sign on ultrasound examination of multiple (poly) ovarian cysts. These "cysts" are actually immature follicles, not cysts ("polyfollicular ovary syndrome" would have been a more accurate name). The follicles have developed from primordial follicles, but the development has stopped ("arrested") at an early antral stage due to the disturbed ovarian function. The follicles may be oriented along the ovarian periphery, appearing as a ‘string of pearls’ on ultrasound examination. The condition was first described in 1935 by Dr. Stein and Dr. Leventhal, hence its original name of Stein-Leventhal syndrome.
PCOS is characterized by a complex set of symptoms, and the cause cannot be determined for all patients. However, research to date suggests that insulin resistance could be a leading cause. PCOS may also have a genetic predisposition, and further research into this possibility is taking place. No specific gene has been identified, and it is thought that many genes could contribute to the development of PCOS.
A majority of patients with PCOS have insulin resistance and/or are obese. Their elevated insulin levels contribute to or cause the abnormalities seen in the hypothalamic-pituitary-ovarian axis that lead to PCOS.
Adipose tissue possesses aromatase, an enzyme that converts androstenedione to estrone and testosterone to estradiol. The excess of adipose tissue in obese patients creates the paradox of having both excess androgens (which are responsible for hirsutism and virilization) and estrogens (which inhibits FSH via negative feedback).
Also, hyperinsulinemia increases GnRH pulse frequency, LH over FSH dominance, increased ovarian androgen production, decreased follicular maturation, and decreased SHBG binding; all these steps lead to the development of PCOS. Insulin resistance is a common finding among patients of normal weight as well as those overweight patients.
One study in the United Kingdom concluded that the risk of PCOS development was shown to be higher in lesbian women than in heterosexuals. It should be noted however that all the participants in this study were referred after infertility was discovered or highly suspected and conclusion made is purely conjecture. Until further studies have been conducted and the research collaborated there is no assumption that female homosexuality will increase the occurrence of PCOS.
Medical treatment of PCOS is tailored to the patient’s goals. Broadly, these may be considered under four categories:
- Lowering of insulin levels
- Restoration of fertility
- Treatment of hirsutism or acne
- Restoration of regular menstruation, and prevention of endometrial hyperplasia and endometrial cancer
Adverse effect of PCOS
- Endometrial hyperplasia/carcinoma
- Diabetes mellitus
- Cardiovascular diseases
- Coronary heart diseases